-

CORRECTING and REPLACING GRAPHIC Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings

Analysis finds that Virta’s diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over two years

by Virta Health

SAN FRANCISCO--(BUSINESS WIRE)--Please replace the graphic with the accompanying corrected graphic.

The release reads:

DIABETES REVERSAL LEADER VIRTA HEALTH EARNS VALIDATION INSTITUTE’S HIGHEST RANKING FOR DELIVERING INDUSTRY-LEADING PRESCRIPTION DRUG SAVINGS

Analysis finds that Virta’s diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over two years

Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institute’s most prominent, Level 1 savings validation for delivering unmatched medication cost reductions. Per the analysis, Virta’s validated prescription drug savings amounted to nearly $6k per patient over a two-year period.

This validation follows similar findings from a claims-based analysis—with methodology verified by an independent actuarial firm—that showed $10k savings per patient over two years. That report analyzed healthcare utilization in addition to prescription medications. Further, Virta previously received the Validation Institute’s Level 2 certification verifying Virta's transformative impact on blood sugar control and weight loss, making it the only vendor in its category to achieve both a cost savings and a health outcomes validation.

Combined, these studies reaffirm Virta’s leadership in delivering evidence-based clinical and financial performance.

"In a crowded marketplace, Virta’s innovative diabetes reversal treatment stands out for its proven impact on health outcomes and for driving significant cost savings," said Benny DiCecca, CEO & President, Validation Institute.

Finding solutions to the diabetes epidemic has never been more critical. The prevalence of diabetes and prediabetes continues to rise, and diabetes-related deaths surged during the pandemic. Meanwhile, payers struggle to manage skyrocketing employee medical costs and insulin prices, while navigating an explosion of digital health vendors with unproven ROI.

Virta offers a clinically and financially validated approach to this crisis. Unlike diabetes management solutions that prioritize medication adherence, Virta’s approach helps patients achieve normal blood sugar while reducing or eliminating diabetes drugs. In Virta’s peer-reviewed evidence, among completing patients at one year, 63% of all diabetes-specific prescriptions are eliminated, and 94% of those using insulin decrease or eliminate their dosage. Patients also see significant improvement in markers of cardiovascular disease and inflammation, and weight loss more than double the FDA benchmark for weight-loss drugs.

To learn more, visit www.virtahealth.com.

About Virta Health:

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by nearly 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit www.virtahealth.com or follow us on Twitter @virtahealth.

About Validation Institute:

Validation Institute is an independent, objective, 3rd party organization on a mission to improve the quality and cost of healthcare. Based in Woburn, MA, the organization is made up of a network of health benefits purchasers, health benefits advisors, and healthcare solution providers focused on delivering better health value and stronger outcomes than conventional healthcare.

Contacts

Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

Virta Health


Release Summary
Virta Health earned the Validation Institute’s most prominent, Level 1 savings validation for delivering unmatched medication cost reductions.
Release Versions

Contacts

Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

Social Media Profiles
More News From Virta Health

New Data Shows Virta Health Closes Gaps in Diabetes Care for Underserved Populations

DENVER--(BUSINESS WIRE)--Virta Health released real-world data at the ADA’s 83rd Scientific Sessions demonstrating how its approach is narrowing gaps in care....

U-Haul, Quartz Health Solutions, and 70+ Other Major Payers Partner with Virta Health to Fight Back Against Obesity Epidemic

DENVER--(BUSINESS WIRE)--Type 2 diabetes reversal leader Virta Health reported substantial growth of its obesity solution over the last three years. Today, the company partners with more than 70 employers and insurers—such as U-Haul and Quartz—that offer Virta’s provider-led weight loss solution in addition to diabetes reversal. Since expanding to address prediabetes and obesity in 2020, demand has accelerated. Currently, 20% of customers offer Virta’s weight loss solution, and 15% of Virta mem...

Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth

DENVER--(BUSINESS WIRE)--Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions. With nearly two decades of industry experience, Manu Diwakar joins as Chief Financial Officer (CFO). Before Virta, Diwakar served as CFO at virtual musculoskeletal treatment company Kaia Health. Diwakar has also held top leadership roles at Ceres Imaging, Victorious (acquired by Headspace), and Riot Ga...
Back to Newsroom